Perlecan Domain V is a Novel Stroke Treatment

Summary

Perlecan domain V (DV) may improve functional stroke outcome. This article discusses findings from a study that investigated the effect of the extracellular matrix fragment perlecan domain V on angiogenesis and neurogenesis in poststroke rats and mice.

  • neurology
  • cerebrovascular disease
  • neurology clinical trials
View Full Text